Study derives Rogue antibodies linked to COVID-19 clotting
A group of researchers, including those from the National Institutes of Health, discovered "rogue antibodies" that correspond with severe disease and may help explain...
Pfizer Joins J&J, Moderna On Price, Tech In Shareholder Vote
It's no secret that pharmaceutical companies have been criticised for their unequal access to COVID-19 vaccines. Oxfam has won several battles to obtain pricing and...
World’s first WHO Maturity Level drug regulator is Singapore
Singapore is the first country in WHO's categorization of regulatory authority for medical goods to obtain the highest maturity level (ML 4) out of...
Strong Protection By New Sanofi Vaccine Against Severe COVID
In the fight against COVID-19, the world may soon have another vaccine choice. A positive result from late-stage clinical testing of a novel vaccine...
Is Pancorona Virus Vaccine Possible? Dr. Weissman Says So
On the opening day of the 19th edition of BioAsia, a special fireside chat between Dr. Sangita Reddy, MD, of Apollo Hospitals and Dr....
WHO Puts In Place Another Training Hub For Biomanufacturing
WHO along with its academy and the Republic of Korea, have announced the inception of a global bio manufacturing training hub that will be...
MNC Pharmaceutical Giants Restructure Their India Presence
Earlier in February this year, Novartis, which happens to be a Swiss drug major, sold its three rooted brands to Dr Reddy’s Laboratories in...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...